Expression of Serum sLOX-1 in Patients with Non-Small-Cell Lung Cancer and Its Correlation with Lipid Metabolism

Table 4

Correlation between sLOX-1, LDL, and clinicopathological characteristics of NSCLC patients.

Variables	sLOX-1 (pg/mL)		value	LDL (mmol/L)		value
	<1733.0	≥1733.0		<2.715	≥2.715
Gender
Male	20	23	>0.38	19	24	0.15
Female	31	25		33	23
Age (years)
<63	26	23	0.76	26	23	0.92
≥63	25	25		26	24
BMI
<23.3	31	25	0.38	33	23	0.15
≥23.3	20	23		19	24
Smoking history
Yes	10	15	>0.18	9	16	0.06
No	41	33		43	31
Histology
Squamous cell carcinoma	9	10	0.69	8	12	0.21
Adenocarcinoma	42	38		44	35
Lymph node metastasis
Yes	12	31	<0.01	16	27	<0.01
No	39	17		36	20
Distant Metastasis
Yes	12	14	<0.01	9	17	<0.05
No	39	34		43	30
TNM stage
I–II	35	14	<0.01	32	17	<0.01
III–IV	16	34		20	30